Pages that link to "Q84353947"
Jump to navigation
Jump to search
The following pages link to PGF isoforms, PLGF-1 and PGF-2, in colorectal cancer and the prognostic significance (Q84353947):
Displaying 14 items.
- Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members (Q34475764) (← links)
- Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis (Q35603983) (← links)
- A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity (Q35604265) (← links)
- A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours (Q35879889) (← links)
- Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike? (Q36936900) (← links)
- Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway (Q36992647) (← links)
- Aflibercept in the treatment of patients with metastatic colorectal cancer: latest findings and interpretations (Q37255848) (← links)
- Overcoming resistance to antiangiogenic therapies (Q38024765) (← links)
- Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. (Q38166233) (← links)
- Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma. (Q42642023) (← links)
- VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma (Q46202577) (← links)
- Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes (Q51052096) (← links)
- Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection (Q83024779) (← links)
- Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study (Q91819867) (← links)